Mereo BioPharma Group Plc (MREO)
0.4239
-0.01
(-1.88%)
USD |
NASDAQ |
Feb 20, 16:00
0.4242
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group SG&A Expense (Quarterly) : 6.009M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 1.886M |
| Autolus Therapeutics Plc | 36.05M |
| Bicycle Therapeutics Plc | 18.74M |
| AstraZeneca PLC | 152.78M |